Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRMD NASDAQ:LIVN NASDAQ:NVCR NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRMDiRadimed$71.99-0.2%$64.74$44.58▼$74.00$915.71M1.0244,605 shs22,289 shsLIVNLivaNova$57.97-0.3%$48.43$32.48▼$58.42$3.17B0.97705,844 shs958,459 shsNVCRNovoCure$12.28+2.5%$13.84$10.87▼$34.13$1.37B0.581.22 million shs1.20 million shsWRBYWarby Parker$26.02+2.6%$24.32$12.69▼$29.73$2.74B2.12.18 million shs1.13 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRMDiRadimed+2.18%-1.21%+3.69%+19.24%+55.04%LIVNLivaNova+2.76%+4.87%+36.47%+26.55%+18.48%NVCRNovoCure-0.83%-0.33%+4.81%-29.53%-28.26%WRBYWarby Parker+0.56%-3.27%+4.38%+17.58%+84.36%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRMDiRadimed$71.99-0.2%$64.74$44.58▼$74.00$915.71M1.0244,605 shs22,289 shsLIVNLivaNova$57.97-0.3%$48.43$32.48▼$58.42$3.17B0.97705,844 shs958,459 shsNVCRNovoCure$12.28+2.5%$13.84$10.87▼$34.13$1.37B0.581.22 million shs1.20 million shsWRBYWarby Parker$26.02+2.6%$24.32$12.69▼$29.73$2.74B2.12.18 million shs1.13 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRMDiRadimed+2.18%-1.21%+3.69%+19.24%+55.04%LIVNLivaNova+2.76%+4.87%+36.47%+26.55%+18.48%NVCRNovoCure-0.83%-0.33%+4.81%-29.53%-28.26%WRBYWarby Parker+0.56%-3.27%+4.38%+17.58%+84.36%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRMDiRadimed 3.00Buy$72.000.01% UpsideLIVNLivaNova 3.00Buy$59.713.01% UpsideNVCRNovoCure 2.57Moderate Buy$28.79134.41% UpsideWRBYWarby Parker 2.58Moderate Buy$24.06-7.51% DownsideCurrent Analyst Ratings BreakdownLatest IRMD, LIVN, WRBY, and NVCR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025LIVNLivaNovaNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$64.008/21/2025LIVNLivaNovaBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$55.00 ➝ $58.008/8/2025WRBYWarby ParkerCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/8/2025WRBYWarby ParkerUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$20.00 ➝ $23.008/8/2025WRBYWarby ParkerStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$21.00 ➝ $22.008/7/2025WRBYWarby ParkerEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingPositive8/7/2025WRBYWarby ParkerTelsey Advisory GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$28.008/7/2025WRBYWarby ParkerBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$24.00 ➝ $28.008/5/2025WRBYWarby ParkerRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetNeutral$24.008/1/2025WRBYWarby ParkerTelsey Advisory GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$22.00 ➝ $28.007/30/2025WRBYWarby ParkerRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$24.00 ➝ $30.00(Data available from 9/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRMDiRadimed$73.24M12.50$1.61 per share44.62$6.85 per share10.51LIVNLivaNova$1.25B2.53$4.34 per share13.35$24.31 per share2.38NVCRNovoCure$605.22M2.27N/AN/A$3.33 per share3.69WRBYWarby Parker$771.32M3.55$0.35 per share74.41$3.35 per share7.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRMDiRadimed$19.23M$1.6244.4436.00N/A26.61%23.30%20.62%10/30/2025 (Estimated)LIVNLivaNova$63.23M-$3.89N/A18.46N/A-16.13%14.57%6.91%10/29/2025 (Estimated)NVCRNovoCure-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/29/2025 (Estimated)WRBYWarby Parker-$20.39M-$0.07N/A260.15N/A-1.12%-0.79%-0.41%11/6/2025 (Estimated)Latest IRMD, LIVN, WRBY, and NVCR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025LIVNLivaNova$0.84$1.05+$0.21$0.50$332.20 million$352.50 million7/24/2025Q2 2025NVCRNovoCure-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRMDiRadimed$0.680.94%N/A41.98%1 YearsLIVNLivaNovaN/AN/AN/AN/AN/ANVCRNovoCureN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ALatest IRMD, LIVN, WRBY, and NVCR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/31/2025IRMDiRadimedquarterly$0.171.13%8/18/20258/18/20258/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRMDiRadimedN/A8.787.51LIVNLivaNova0.311.291.09NVCRNovoCure0.281.451.39WRBYWarby ParkerN/A2.552.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRMDiRadimed92.34%LIVNLivaNova97.64%NVCRNovoCure84.61%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipIRMDiRadimed36.80%LIVNLivaNova0.29%NVCRNovoCure5.52%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRMDiRadimed11012.72 million8.04 millionOptionableLIVNLivaNova2,90054.60 million54.44 millionOptionableNVCRNovoCure1,488111.80 million105.63 millionOptionableWRBYWarby Parker3,780105.19 million86.00 millionOptionableIRMD, LIVN, WRBY, and NVCR HeadlinesRecent News About These Companies12 West Capital Management LP Invests $21.42 Million in Warby Parker Inc. $WRBYSeptember 5 at 6:08 AM | marketbeat.comWarby Parker Inc. (WRBY) Presents At Goldman Sachs 32nd Annual Global Retailing Conference 2025 TranscriptSeptember 4 at 2:09 PM | seekingalpha.comUNC Management Company Inc. Buys Shares of 12,798 Warby Parker Inc. $WRBYSeptember 4 at 7:28 AM | marketbeat.comPDT Partners LLC Purchases 110,789 Shares of Warby Parker Inc. $WRBYSeptember 4 at 6:26 AM | marketbeat.comPanagora Asset Management Inc. Acquires 15,319 Shares of Warby Parker Inc. $WRBYSeptember 4 at 5:23 AM | marketbeat.comMagnetar Financial LLC Buys Shares of 24,065 Warby Parker Inc. $WRBYSeptember 4 at 5:04 AM | marketbeat.comDurable Capital Partners LP Increases Stake in Warby Parker Inc. $WRBYSeptember 3 at 7:50 AM | marketbeat.comMaverick Capital Ltd. Makes New $5.04 Million Investment in Warby Parker Inc. $WRBYSeptember 3 at 7:30 AM | marketbeat.comOMERS ADMINISTRATION Corp Acquires 59,600 Shares of Warby Parker Inc. $WRBYSeptember 3 at 5:00 AM | marketbeat.comDriehaus Capital Management LLC Lowers Stock Holdings in Warby Parker Inc. $WRBYSeptember 2 at 5:56 AM | marketbeat.comHsbc Holdings PLC Cuts Holdings in Warby Parker Inc. $WRBYSeptember 2 at 3:58 AM | marketbeat.comWarby Parker Inc. $WRBY Shares Acquired by Trexquant Investment LPSeptember 1, 2025 | marketbeat.comAlphaQuest LLC Acquires 13,393 Shares of Warby Parker Inc. $WRBYSeptember 1, 2025 | marketbeat.comInvesco Ltd. Cuts Stake in Warby Parker Inc. $WRBYSeptember 1, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Stock Rating Upgraded by Wall Street ZenSeptember 1, 2025 | marketbeat.comWarby Parker Inc. $WRBY Shares Sold by Clough Capital Partners L PAugust 31, 2025 | marketbeat.comBroad Bay Capital Management LP Invests $14.36 Million in Warby Parker Inc. $WRBYAugust 31, 2025 | marketbeat.comLandscape Capital Management L.L.C. Buys 12,290 Shares of Warby Parker Inc. $WRBYAugust 31, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Upgraded to Buy at Wall Street ZenAugust 31, 2025 | americanbankingnews.com87,616 Shares in Warby Parker Inc. $WRBY Bought by Mission Creek Capital Partners Inc.August 30, 2025 | marketbeat.comWarby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing ConferenceAugust 28, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIRMD, LIVN, WRBY, and NVCR Company DescriptionsiRadimed NASDAQ:IRMD$71.99 -0.15 (-0.21%) Closing price 04:00 PM EasternExtended Trading$72.06 +0.07 (+0.09%) As of 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.LivaNova NASDAQ:LIVN$57.97 -0.18 (-0.31%) Closing price 04:00 PM EasternExtended Trading$58.00 +0.02 (+0.04%) As of 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.NovoCure NASDAQ:NVCR$12.28 +0.30 (+2.50%) Closing price 04:00 PM EasternExtended Trading$12.29 +0.01 (+0.08%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.Warby Parker NYSE:WRBY$26.02 +0.67 (+2.62%) Closing price 03:59 PM EasternExtended Trading$25.56 -0.46 (-1.75%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Affirm Crushes Earnings Expectations, Turns Bears into Believers Lockheed Martin: Is the Market Overlooking This Defensive Giant? Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
